John Watt, of the Scottish National Blood Transfusion Service, reported to the DHSS that a fifth of stored plasma had been processed. Read more about John Watt, of the Scottish National Blood Transfusion Service, reported to the DHSS that a fifth of stored plasma had been processed.
It was agreed that Scotland should provide its own supply of fractions before undertaking work for the NBTS in England. Read more about It was agreed that Scotland should provide its own supply of fractions before undertaking work for the NBTS in England.
Transfusion directors agreed at an SNBTS meeting that Mr Watt could process a limited amount of plasma from BPL to establish yield and costs. Read more about Transfusion directors agreed at an SNBTS meeting that Mr Watt could process a limited amount of plasma from BPL to establish yield and costs.
It was agreed at a SNBTS meeting that no start should be made on the large-scale processing of plasma from England and Wales until a plan had been agreed by transfusion directors. Read more about It was agreed at a SNBTS meeting that no start should be made on the large-scale processing of plasma from England and Wales until a plan had been agreed by transfusion directors.
It was reported at a DHSS meeting that the Minister of State stressed the need for cooperation between Scotland and England in manufacturing blood products. Read more about It was reported at a DHSS meeting that the Minister of State stressed the need for cooperation between Scotland and England in manufacturing blood products.
The Scottish Home Health Department asked the DHSS when the Protein Fractionation Centre would be provided with English plasma for fractionation. Read more about The Scottish Home Health Department asked the DHSS when the Protein Fractionation Centre would be provided with English plasma for fractionation.
In his evidence, Dr Foster explained that John Watt considered a fractionation centre should support a population of at least 15 million to be economically viable meaning that the population of Scotland was too small, in his opinion, for the Protein Fractionation Centre to be economically viable, and he saw England as essential to the future survival of the Centre, as well as of benefit to England. Read more about In his evidence, Dr Foster explained that John Watt considered a fractionation centre should support a population of at least 15 million to be economically viable meaning that the population of Scotland was too small, in his opinion, for the Protein Fractionation Centre to be economically viable, and he saw England as essential to the future survival of the Centre, as well as of benefit to England.
At the minimum level of working, it was expected that 1,000 litres of plasma would come from Scotland each week, and the remaining 500 litres would come from England. John Watt questioned how this would work since there was no available plasma in England available at that time. Read more about At the minimum level of working, it was expected that 1,000 litres of plasma would come from Scotland each week, and the remaining 500 litres would come from England. John Watt questioned how this would work since there was no available plasma in England available at that time.
The Expert Group on the Treatment of Haemophilia emphasised the importance of taking a UK view of provision for haemophilia therapy. Read more about The Expert Group on the Treatment of Haemophilia emphasised the importance of taking a UK view of provision for haemophilia therapy.
Treasury approval was given to a final cost limit of £1,728,079 for the work on the Protein Fractionation Centre. Read more about Treasury approval was given to a final cost limit of £1,728,079 for the work on the Protein Fractionation Centre.